🏆 We made it! We are the winner of the Swiss Medtech Award 2022 🙏 A big thank you to the AlveoliX team for their commitment and to all the people who support us.– ARTORG Center for Biomedical Engineering Research– Insel Gruppe– Innosuisse– Bern Economic Development Agency 👏🏼 Thank you to the jury for choosing AlveoliX and to the…

🌐 CSL Behring, Insel Gruppe and AlveoliX have joined forces within sitem-insel AG’s hub to improve translation and find new treatments for lung diseases.  🔬 Discover how this close collaboration works for the benefit of patients. 📰  Learn more about this cooperation success story in this article by Jasmin Joller (available in EN, DE, FR). 

🔥 We are very excited to announce our partnership with InSCREENeX GmbH. 🤝 By joining forces and combining InSCREENeX’ cutting-edge CI-SCREEN methodology with AlveoliX’ patented organ-on-chip technology, we co-developed a new immortalized alveolar cell line, specially tuned for on-chip applications. 🧫 AXiAECs derived from primary alveolar epithelial cells and grown on-chip feature key aspects of the distal…

🏅 AlveoliX has been shortlisted for the Swiss Medtech Award 2022!   🌟 We will be pitching our company to the Jury on April 6th. Looking forward to the hearing!  🙏🏻 Thank you Swiss Medtech for choosing AlveoliX as one of the 6 companies invited to participate in the vibrant Swiss Medtech Award 2022.  🔗 More info about the shortlisted…

🏆 AlveoliX is part of the Top 5 Startup out of 594 building Lab-on-a-Chip Solutions!  🔸 Interested in discovering other emerging technologies? Check out the article.  🙏🏼 Thank you StartUs Insights for featuring us. 

🎂 Happy Birthday to AlveoliX!🥂 We are thrilled and thankful to celebrate our 3rd anniversary.🤗 Thank you to all those who have trusted and supported us. We keep working to improve our range of applications and increase accessibility to our technology. Because we are stronger together.

Are you interested in using microphysiological systems in your research?  Check out the new NA3RsC MPS Hub, a new, user-friendly resource for you that highlights MPS providers with commercially available technologies.  In this hub, you can quickly sort by organ-type(s) offered, access top 3 publications, links to company websites, and find contact information. And you’ll know that all members are supporters…

Last week we had the pleasure to host our partners from Roche Basel in the first Biochip Storming AX event. Throughout the different sessions, we addressed the challenges and opportunities of the organ-on-chip technology within the drug development pipeline. Thanks to Lauriane CABON and all the participants for making it such as successful day, full of exciting…

We are proud to be part of The North American 3Rs Collaborative’s (NA3RsC) Micro Physiological Systems (MPS) initiative. The MPS initiative works together to increase industry adoption and regulatory acceptance of MPS technologies with the ultimate goal of refining, reducing, and replacing research animals. Learn more about our efforts in this group on the NA3RsC…